News Releases
Drug Application for Atrial Fibrillation
Bristol-Myers Squibb Company and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for Eliquis ( apixaban ), an investigational compound for the prevention of stroke and systemic embolism in patients with atrial fibrillation.
Diabetes: It Isn't Getting Better
Nearly 26 million Americans have diabetes, and another 79 million have prediabetes. That's about 30 percent of all Americans with a diabetes problem.